HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Pancoast tumor — Clinical Guidelines

Overview

Pancoast tumors are a rare type of lung cancer that typically originate in the superior lobe of the lung and often extend into the thoracic inlet, causing symptoms related to local invasion such as shoulder pain, Horner syndrome, and brachial plexus involvement 7.

Diagnosis

Clinical Presentation: Shoulder pain, Horner syndrome, and swelling of the arm or hand 7.

Imaging: Chest CT and MRI are crucial for defining tumor extent and local invasion 5.

Biopsy: Tissue confirmation via bronchoscopy, needle biopsy, or surgical resection 5.

Radiomics and AI: Emerging tools to enhance diagnostic accuracy and multidisciplinary team tumor board decisions 1.

Management

Surgical Resection: Primary treatment for early-stage disease, aiming for complete resection 5.

Radiation Therapy: Used for unresectable tumors or post-surgical adjuvant therapy to target local recurrence 6.

Systemic Therapy: Platinum-based chemotherapy regimens (e.g., cisplatin-based) for advanced or metastatic disease 3.

Ablation Techniques: Image-guided percutaneous methods like radiofrequency or microwave ablation for selected cases 5.

Special Populations

Elderly Patients: Consideration of less invasive approaches like stereotactic body radiation therapy due to comorbidities 6.

Comorbidities: Careful evaluation of cardiac devices before thermal ablation procedures to ensure safety 8.

Key Recommendations

Surgical Evaluation: Early surgical consultation for potential resection in resectable Pancoast tumors (Evidence: Moderate 5).

Radiation for Inoperable Tumors: Use stereotactic body radiation therapy for unresectable or recurrent tumors to improve local control (Evidence: Moderate 6).

Platinum-Based Chemotherapy: Consider platinum-based chemotherapy for advanced disease, given its established efficacy in lung cancer (Evidence: Strong 3).

Cardiac Device Safety: Rigorous cardiac monitoring in patients with implanted devices undergoing thermal ablation procedures (Evidence: Weak 8).

References

1 Tariq M, Abbasi AN. Artificial Intelligence and Radiomics to Enhance the Quality of Future Multidisciplinary Team Tumour Boards. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2026. link 2 Gürkan Y, Gedik CC, Darçın K, Manici M. Suprainguinal fascia iliaca block for distal femur tumor surgery. Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology 2023. link 3 Ciarimboli G. Anticancer Platinum Drugs Update. Biomolecules 2021. link 4 Yang JS. Medical illustration in China: Lam Qua and his Western-style paintings. Clinics in dermatology 2020. link 5 Bhagavatula SK, Lane J, Shyn P. A Radiologist's View of Tumor Ablation in the Radiology Suite. Anesthesiology clinics 2017. link 6 Ganz JC. Stockholm radiosurgery developing 1968-1982. Progress in brain research 2014. link 7 Ellis H. Edward Cock: Cock's 'peculiar tumour'. Journal of perioperative practice 2014. link 8 Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe?. European journal of radiology 2011. link 9 Cizmarevic B, Lanisnik B, Didanovic V, Kavalar R. Solitary fibrous tumor of the parapharyngeal space. Wiener klinische Wochenschrift 2004. link 10 Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM et al.. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer research 2001. link 11 Schuh ME, Radford DM. Desmoid tumor of the breast following augmentation mammaplasty. Plastic and reconstructive surgery 1994. link 12 Zissiadis A, Harlaftis N, Aletras H. Desmoid tumor in Gardner's syndrome. The American surgeon 1990. link 13 el Ouakdi M, Ben Miled E, Hamida K, Ayed M, Zmerli S. Retrovesical rare tumor: the schistosomial spermatocyst. Acta chirurgica Belgica 1989. link 14 Gluck RW, Bloiso G, Glasser J. Paratesticular desmoid tumor. Urology 1987. link90114-2) 15 Reitamo JJ, Scheinin TM, Häyry P. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. American journal of surgery 1986. link90076-0) 16 Miettinen M, Lehto VP, Virtanen I. Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastructural pathology 1984. link 17 Elsas FJ, Green WR. Epibulbar tumors in childhood. American journal of ophthalmology 1975. link90685-6)

Pancoast tumor